{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-111279","form_type":"8-K","ticker":"COCH","cik":"0001840877","company_name":"Envoy Medical, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.974039+00:00","generated_at":"2026-05-29T00:30:12.091621+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Envoy Medical enters Conversion and Waiver Agreement with sponsor, modifying preferred stock terms and converting shares","bullets":["Sponsor Anzu waives $3,733,333 in accrued dividends on Series A Preferred Stock.","Envoy waives vesting restrictions on 1,000,000 restricted shares held by Anzu.","Conversion price on Preferred Stock temporarily reduced from $11.50 to $3.63 per share through Jan 20, 2025.","Anzu converts 373,333 Preferred Stock shares into 1,028,986 shares of common stock.","Agreement executed December 20, 2024, closing same day."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-111279","json":"https://secwatch.observer/filing/0001213900-24-111279.json","markdown":"https://secwatch.observer/filing/0001213900-24-111279.md","text":"https://secwatch.observer/filing/0001213900-24-111279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/0001213900-24-111279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/ea0225604-8k_envoy.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-29T00:30:12.091621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}